Amedisys Inc (AMED): Price and Financial Metrics


Amedisys Inc (AMED): $90.26

-0.25 (-0.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AMED POWR Grades

  • AMED scores best on the Quality dimension, with a Quality rank ahead of 94.39% of US stocks.
  • AMED's strongest trending metric is Quality; it's been moving down over the last 177 days.
  • AMED ranks lowest in Sentiment; there it ranks in the 9th percentile.

AMED Stock Summary

  • AMEDISYS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 75.52% of US listed stocks.
  • AMEDISYS INC's stock had its IPO on September 2, 1994, making it an older stock than 77.36% of US equities in our set.
  • The price/operating cash flow metric for AMEDISYS INC is higher than 83.23% of stocks in our set with a positive cash flow.
  • If you're looking for stocks that are quantitatively similar to AMEDISYS INC, a group of peers worth examining would be MCRI, GXO, CPHC, PRG, and DY.
  • Visit AMED's SEC page to see the company's official filings. To visit the company's web site, go to www.amedisys.com.

AMED Valuation Summary

  • AMED's EV/EBIT ratio is 18.9; this is 117.24% higher than that of the median Healthcare stock.
  • AMED's EV/EBIT ratio has moved up 14.6 over the prior 243 months.

Below are key valuation metrics over time for AMED.

Stock Date P/S P/B P/E EV/EBIT
AMED 2022-12-02 1.3 2.9 24.6 18.9
AMED 2022-12-01 1.3 2.9 24.4 18.8
AMED 2022-11-30 1.3 2.9 24.5 18.8
AMED 2022-11-29 1.3 2.8 23.8 18.3
AMED 2022-11-28 1.3 2.9 24.2 18.6
AMED 2022-11-25 1.3 2.9 24.5 18.8

AMED Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at 241.73%.
  • Its 2 year cash and equivalents growth rate is now at -60.12%.
  • Its 2 year revenue growth rate is now at 12.23%.
Over the past 52 months, AMED's revenue has gone up $625,186,000.

The table below shows AMED's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 2,220.452 97.566 120.939
2022-06-30 2,215.949 172.963 140.303
2022-03-31 2,222.225 183.512 190.873
2021-12-31 2,214.112 188.893 209.072
2021-09-30 2,205.5 249.639 220.176
2021-06-30 2,196.085 270.955 247.151

AMED's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMED has a Quality Grade of A, ranking ahead of 99.52% of graded US stocks.
  • AMED's asset turnover comes in at 1.321 -- ranking 11th of 81 Healthcare stocks.
  • RDNT, CHE, and VCYT are the stocks whose asset turnover ratios are most correlated with AMED.

The table below shows AMED's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 1.321 0.446 0.742
2021-06-30 1.385 0.449 0.838
2021-03-31 1.325 0.435 0.601
2020-12-31 1.325 0.428 0.465
2020-09-30 1.359 0.419 0.395
2020-06-30 1.419 0.409 0.355

AMED Price Target

For more insight on analysts targets of AMED, see our AMED price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $240.92 Average Broker Recommendation 1.62 (Moderate Buy)

AMED Stock Price Chart Interactive Chart >

Price chart for AMED

AMED Price/Volume Stats

Current price $90.26 52-week high $179.91
Prev. close $90.51 52-week low $83.00
Day low $90.26 Volume 1,383
Day high $90.26 Avg. volume 386,153
50-day MA $93.22 Dividend yield N/A
200-day MA $121.33 Market Cap 2.93B

Amedisys Inc (AMED) Company Bio


Amedisys provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The company was founded in 1982 and is based in Baton Rouge, Louisiana.


AMED Latest News Stream


Event/Time News Detail
Loading, please wait...

AMED Latest Social Stream


Loading social stream, please wait...

View Full AMED Social Stream

Latest AMED News From Around the Web

Below are the latest news stories about AMEDISYS INC that investors may wish to consider to help them evaluate AMED as an investment opportunity.

Amedisys Names Scott Ginn Acting Chief Operating Officer

BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immediately. “I am delighted to have Scott Ginn serving as a trusted partner in this critical role on our leadership team,” stated Paul Kusserow, Chairman and CEO of Amedisys. “Scott is well respected within Amedisys an

Yahoo | November 22, 2022

Last week in management changes and dispatches: Visa, Tesla

Here are the biggest management changes and dispatches from the past week, as first reported on InvestingPro+.

Yahoo | November 20, 2022

Amedisys Inc. terminates president and CEO, effective immediately

A publicly traded home health and hospice company is shaking up its C-suite. The company’s board of directors appointed Amedisys Chairman and former CEO Paul Kusserow as interim CEO until a permanent replacement is found. Kusserow previously worked as Amedisys’ CEO from 2014 until April, when Gerard was hired.

Yahoo | November 18, 2022

Are Options Traders Betting on a Big Move in Amedisys (AMED) Stock?

Investors need to pay close attention to Amedisys (AMED) stock based on the movements in the options market lately.

Yahoo | November 18, 2022

Amedisys Confirms Full Year Guidance

Today, the Board of Directors of Amedisys, Inc. (NASDAQ: AMED) announced a leadership change that President and Chief Executive Officer, Chris Gerard, will leave the company effective November 17, 2022, and Paul Kusserow, Chair of the Board of Directors will take over as Chief Executive Officer until a new Chief Executive Officer is identified.

Yahoo | November 18, 2022

Read More 'AMED' Stories Here

AMED Price Returns

1-mo 4.38%
3-mo -23.11%
6-mo -21.55%
1-year -37.52%
3-year -45.90%
5-year 65.52%
YTD -44.24%
2021 -44.81%
2020 75.73%
2019 42.53%
2018 122.18%
2017 23.65%

Continue Researching AMED

Here are a few links from around the web to help you further your research on Amedisys Inc's stock as an investment opportunity:

Amedisys Inc (AMED) Stock Price | Nasdaq
Amedisys Inc (AMED) Stock Quote, History and News - Yahoo Finance
Amedisys Inc (AMED) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8092 seconds.